BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1336063)

  • 1. Deferoxamine, an iron chelator, reduces myocardial injury and free radical generation in isolated neonatal rabbit hearts subjected to global ischaemia-reperfusion.
    Katoh S; Toyama J; Kodama I; Akita T; Abe T
    J Mol Cell Cardiol; 1992 Nov; 24(11):1267-75. PubMed ID: 1336063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.
    Katoh S; Toyama J; Kodama I; Kamiya K; Akita T; Abe T
    Eur Surg Res; 1992; 24(6):349-55. PubMed ID: 1338045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine reduces the reperfusion injury in isolated neonatal rabbit hearts after hypothermic preservation.
    Katoh S; Toyama J; Kodama I; Kamiya K; Akita T; Abe T
    Surg Today; 1993; 23(5):424-9. PubMed ID: 8391884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.
    Ambrosio G; Zweier JL; Jacobus WE; Weisfeldt ML; Flaherty JT
    Circulation; 1987 Oct; 76(4):906-15. PubMed ID: 2820615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts.
    Tosaki A; Droy-Lefaix MT; Pali T; Das DK
    Free Radic Biol Med; 1993 Apr; 14(4):361-70. PubMed ID: 8385645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts.
    Williams RE; Zweier JL; Flaherty JT
    Circulation; 1991 Mar; 83(3):1006-14. PubMed ID: 1847847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309.
    Katoh S; Toyama J; Kodama I; Koike A; Abe T
    Cardiovasc Res; 1993 Aug; 27(8):1430-4. PubMed ID: 8221795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the effects of antioxidants and inhibitors of radical generation on free radical production in the reperfused rat heart using electron spin resonance spectroscopy.
    Shuter SL; Davies MJ; Garlick PB; Hearse DJ; Slater TF
    Free Radic Res Commun; 1990; 9(3-6):223-32. PubMed ID: 2167260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of ESR and HPLC methods for the detection of OH. radicals in ischemic/reperfused hearts. A relationship between the genesis of free radicals and reperfusion arrhythmias.
    Tosaki A; Bagchi D; Pali T; Cordis GA; Das DK
    Biochem Pharmacol; 1993 Feb; 45(4):961-9. PubMed ID: 8383970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow.
    Ambrosio G; Weisfeldt ML; Jacobus WE; Flaherty JT
    Circulation; 1987 Jan; 75(1):282-91. PubMed ID: 3791610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts.
    Myers CL; Weiss SJ; Kirsh MM; Shepard BM; Shlafer M
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):281-9. PubMed ID: 3945095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the production of oxygen-centered free radicals during electrolysis using E.S.R. spin-trapping techniques: effects on cardiac function in the isolated rat heart.
    Lecour S; Baouali AB; Maupoil V; Chahine R; Abadie C; Javouhey-Donzel A; Rochette L; Nadeau R
    Free Radic Biol Med; 1998 Mar; 24(4):573-9. PubMed ID: 9559869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart protection and radical trapping by DMPO during reperfusion in isolated working rat hearts.
    Tosaki A; Blasig IE; Pali T; Ebert B
    Free Radic Biol Med; 1990; 8(4):363-72. PubMed ID: 2165975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant extracellular-superoxide dismutase type C improves cardioplegic protection against ischemia/reperfusion injury in isolated rat heart.
    Pisarenko OI; Studneva IM; Lakomkin VL; Timoshin AA; Kapelko VI
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):655-63. PubMed ID: 7528849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts.
    Akita T; Abe T; Kato S; Kodama I; Toyama J
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of peroxynitrite precursors, NO and O2, at the onset of reperfusion improves myocardial recovery.
    Falk JA; Aune SE; Kutala VK; Kuppusamy P; Angelos MG
    Resuscitation; 2007 Sep; 74(3):508-15. PubMed ID: 17418932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBN spin trapping of free radicals in the reperfusion-injured heart. Limitations for pharmacological investigations.
    Vrbjar N; Zöllner S; Haseloff RF; Pissarek M; Blasig IE
    Mol Cell Biochem; 1998 Sep; 186(1-2):107-15. PubMed ID: 9774191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium bound extracellular superoxide dismutase type C reduces damage in reperfused ischaemic rat hearts.
    Sjöquist PO; Marklund SL
    Cardiovasc Res; 1992 Apr; 26(4):347-50. PubMed ID: 1638565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of reperfusion injury in ischemic-reperfused hearts by oxypurinol and allopurinol.
    LoBalsamo L; Bergsland J; Lajos P; Feldman MJ
    Transpl Int; 1989 Dec; 2(4):218-22. PubMed ID: 2627264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.